Karyopharm Therapeutics
KPTI
KPTI
147 hedge funds and large institutions have $364M invested in Karyopharm Therapeutics in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 149 → 147 (-2)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
Holders
147
Holding in Top 10
1
Calls
$3.53M
Puts
$2.07M
Top Buyers
| 1 | +$8.35M | |
| 2 | +$8.26M | |
| 3 | +$7.65M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.63M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.23M |
Top Sellers
| 1 | -$7.38M | |
| 2 | -$7.14M | |
| 3 | -$5.85M | |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$4.96M |
| 5 |
Two Sigma Investments
New York
|
-$4.34M |